News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Kazunari Yoshida, MD, PhD

Articles by Kazunari Yoshida, MD, PhD

Using Pharmacogenetics in Making Treatment Decisions for Schizophrenia

ByKazunari Yoshida, MD, PhD,Daniel J. Müller, MD, PhD

March 29th 2019

Latest Updated Articles

Using Pharmacogenetics in Making Treatment Decisions for Schizophrenia
March 29th 2019

Trending on Psychiatric Times

Remlifanserin for the Treatment of Alzheimer Disease Psychosis Receives FDA Fast Track Designation

Targeting APOE4: A Promising Therapeutic Strategy for Alzheimer Disease

Future DSM Plans Overlook Core Problem of Validity

Bipolar Disorder in Women of Childbearing Age: Proper Treatment Before Pregnancy

Classic Drug, New Target: Lithium as Disease-Modifying in Alzheimer Dementia